{"id":359,"date":"2026-08-27T09:41:04","date_gmt":"2026-08-27T09:41:04","guid":{"rendered":"https:\/\/nhdbio.com\/products\/retatrutide\/"},"modified":"2026-08-27T10:09:59","modified_gmt":"2026-08-27T10:09:59","slug":"retatrutide","status":"publish","type":"product_family","link":"https:\/\/nhdbio.com\/de\/products\/retatrutide\/","title":{"rendered":"Retatrutide"},"content":{"rendered":"<p>Retatrutide research product family covering triple GIP, GLP-1 and glucagon receptor pharmacology, available variants, technical identity, quality-document requests, Phase 2 evidence and active clinical-development status. Catalog identifiers: RT5, RT10, RT15, RT20, RT30, RT40, RT50, RT60, RT100.<\/p>","protected":false},"excerpt":{"rendered":"<p>Retatrutide ist ein in der Entwicklung befindlicher Peptidagonist, der die Rezeptoren GIP, GLP-1 und Glucagon aktivieren soll. Ver\u00f6ffentlichte Phase-2-Forschung berichtet \u00fcber K\u00f6rpergewicht und Stoffwechselergebnisse in einer kontrollierten Humanstudie. FDA gibt an, dass Retatrutid kein Bestandteil eines zugelassenen Arzneimittels ist und sich bei keiner Erkrankung als sicher und wirksam erwiesen hat. Dieses Katalogmaterial dient ausschlie\u00dflich Forschungszwecken.<\/p>","protected":false},"author":0,"featured_media":601,"template":"","class_list":["post-359","product_family","type-product_family","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Retatrutide Research Product | Triple Agonist Evidence &amp; Variants<\/title>\n<meta name=\"description\" content=\"Review retatrutide research product variants, triple GIP\/GLP-1\/glucagon receptor mechanism, Phase 2 evidence, investigational status and lot documentation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/products\/retatrutide\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Retatrutide\" \/>\n<meta property=\"og:description\" content=\"Review retatrutide research product variants, triple GIP\/GLP-1\/glucagon receptor mechanism, Phase 2 evidence, investigational status and lot documentation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/products\/retatrutide\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-27T10:09:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/retatrutide-product-family-mockup-20260828.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/\",\"name\":\"Retatrutide Research Product | Triple Agonist Evidence & Variants\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/product-family-mockups\\\/retatrutide-product-family-mockup-20260828.webp\",\"datePublished\":\"2026-08-27T09:41:04+00:00\",\"dateModified\":\"2026-08-27T10:09:59+00:00\",\"description\":\"Review retatrutide research product variants, triple GIP\\\/GLP-1\\\/glucagon receptor mechanism, Phase 2 evidence, investigational status and lot documentation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/product-family-mockups\\\/retatrutide-product-family-mockup-20260828.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/product-family-mockups\\\/retatrutide-product-family-mockup-20260828.webp\",\"width\":1536,\"height\":1024,\"caption\":\"AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/retatrutide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u4ea7\u54c1\u5bb6\u65cf\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/products\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Retatrutide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Retatrutide Forschungsprodukt | Beweise und Varianten f\u00fcr dreifache Agonisten","description":"\u00dcberpr\u00fcfen Sie die Retatrutid-Forschungsproduktvarianten, den dreifachen GIP\/GLP-1\/Glucagon-Rezeptor-Mechanismus, Phase-2-Nachweis, den Untersuchungsstatus und die Chargendokumentation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/products\/retatrutide\/","og_locale":"de_DE","og_type":"article","og_title":"Retatrutide","og_description":"Review retatrutide research product variants, triple GIP\/GLP-1\/glucagon receptor mechanism, Phase 2 evidence, investigational status and lot documentation.","og_url":"https:\/\/nhdbio.com\/de\/products\/retatrutide\/","og_site_name":"NHD","article_modified_time":"2026-08-27T10:09:59+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/retatrutide-product-family-mockup-20260828.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/products\/retatrutide\/","url":"https:\/\/nhdbio.com\/products\/retatrutide\/","name":"Retatrutide Forschungsprodukt | Beweise und Varianten f\u00fcr dreifache Agonisten","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/products\/retatrutide\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/products\/retatrutide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/retatrutide-product-family-mockup-20260828.webp","datePublished":"2026-08-27T09:41:04+00:00","dateModified":"2026-08-27T10:09:59+00:00","description":"\u00dcberpr\u00fcfen Sie die Retatrutid-Forschungsproduktvarianten, den dreifachen GIP\/GLP-1\/Glucagon-Rezeptor-Mechanismus, Phase-2-Nachweis, den Untersuchungsstatus und die Chargendokumentation.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/products\/retatrutide\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/products\/retatrutide\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/products\/retatrutide\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/retatrutide-product-family-mockup-20260828.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/product-family-mockups\/retatrutide-product-family-mockup-20260828.webp","width":1536,"height":1024,"caption":"AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/products\/retatrutide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"\u4ea7\u54c1\u5bb6\u65cf","item":"https:\/\/nhdbio.com\/products\/"},{"@type":"ListItem","position":3,"name":"Retatrutide"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family\/359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/product_family"}],"version-history":[{"count":3,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family\/359\/revisions"}],"predecessor-version":[{"id":439,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/product_family\/359\/revisions\/439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/601"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}